Amerisource Health Services is recalling approximately 7,198 cartons of Prazosin Hydrochloride, a blood pressure medication, because testing found an impurity called N-nitroso Prazosin above acceptable safety limits. The recall affects 1 mg, 2 mg, and 5 mg capsules distributed nationwide under the American Health Packaging brand. Consumers should check their medication against the specific lot numbers and expiration dates to determine if their product is affected.
The product contains N-nitroso Prazosin impurity C at levels exceeding acceptable intake limits. This impurity is classified as a potential carcinogen, meaning long-term exposure above safety thresholds may increase the risk of developing cancer.
You have 2 options:
Rx only; Distributed by American Health Packaging, Columbus, Ohio
Rx only; Distributed by American Health Packaging, Columbus, Ohio
Rx only; Distributed by American Health Packaging, Columbus, Ohio
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.